World first jab to stop skin cancer trialled in UK | Tech & Science Daily podcast [Video]

Find and listen to Tech & Science Daily here: https://pod.fo/e/2354d9
British patients are set to trial a new jab which it’s hoped could stop some cancers in their tracks.
The mRNA jab is custom-built for each person in just a few weeks, and it works by telling the body to hunt down cancer cells and prevent the deadly disease from coming back.
The “game changer” injection is designed for people with melanoma, but it has the potential to stop lung, bladder and kidney cancer as well.
A stage 2 trial of the jab, involving pharma firms Moderna and MSD, found it dramatically reduced the risk of the cancer returning in melanoma patients, and now this final phase 3 trial is being led by University College London Hospitals NHS Foundation Trust.
Steve Young, a music teacher who was diagnosed with melanoma a decade after finding a “bump on his head” is one of the patients receiving the jab.
The “game changer” injection is designed for people with melanoma, but it has the potential to stop lung, bladder and kidney cancer as well.

Subscribe to the Evening Standard: https://bit.ly/Subscribe-to-Evening-Standard
for latest breaking news from the UK, US and around the world, plus podcasts and features.

Evening Standard on socials:
Check out our full video catalog: https://www.youtube.com/c/LondonEveningStandard/videos
Videos, daily editorial and more: https://www.standard.co.uk/
Like us on Facebook: https://www.fb.com/eveningstandard
Follow us on Twitter: https://twitter.com/eveningstandard
and Instagram: https://www.instagram.com/evening.standard